EU

Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial

Retrieved on: 
월요일, 6월 10, 2024
Research, Genetics, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Other Science, Patient, Doctor of Philosophy, Therapy, Clinical trial, Safety, ATR, Survival, MD, Lung cancer, Pharmacokinetics, Treatment, Pharmaceutical industry

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s camonsertib monotherapy non-small cell lung cancer (NSCLC) expansion of the TRESR clinical trial.

Key Points: 
  • Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s camonsertib monotherapy non-small cell lung cancer (NSCLC) expansion of the TRESR clinical trial.
  • “Camonsertib has demonstrated a promising signal of prolonged progression free survival in patients with ATM-mutated NSCLC in our ongoing TRESR clinical trial.
  • With limited treatments for recurrent NSCLC, camonsertib offers a highly desirable oral therapy option with an established safety profile.
  • Repare expects a potential data readout in the camonsertib monotherapy NSCLC expansion in 2025.

B2Prime and cTrader Expand Trading Opportunities with a New Partnership

Retrieved on: 
월요일, 6월 10, 2024
Apps, Applications, Mobile, Wireless, Technology, Finance, Fintech, Professional Services, Software, Data Management, Asset Management, Other Professional Services, Crypto, Multimedia, FIX, ALGO, Ecosystem, Metal, DOM, Medium (website), Commodity, Environment, API, Android, Partnership, UI, IOS, Financial services

B2Prime , a leading global multi-asset and multi-market Prime of Prime liquidity provider, and Spotware , a premier and innovative trading platform provider, have announced a strategic partnership .

Key Points: 
  • B2Prime , a leading global multi-asset and multi-market Prime of Prime liquidity provider, and Spotware , a premier and innovative trading platform provider, have announced a strategic partnership .
  • View the full release here: https://www.businesswire.com/news/home/20240610848632/en/
    B2Prime, a Prime of Prime multi-asset liquidity provider, and cTrader, Spotware's flagship trading platform, have established a strategic partnership to expand trading opportunities.
  • Multi-asset trading without latency → A diverse range of supported asset classes alongside lightning-fast order entry and execution.
  • “We are excited to continuously develop our liquidity provision network, expand the asset offering and enhance the reliability of our trading environment.

Power Integrations Revs Up Motor-Drive Offering With BridgeSwitch-2 BLDC IC Family

Retrieved on: 
화요일, 6월 11, 2024
Semiconductor, Consumer Electronics, Technology, Other Technology, Software, Networks, Hardware, PCB, Multimedia, FOC, IPMS, IPH, MISRA, DC motor, RS Group plc, IHB, BLDC, Certification, IEC, Digi-Key, EMI, Vector control (motor), Architecture, Power, ICS, IGBT, Electric motor

BridgeSwitch-2 is supported by Power Integrations’ MotorXpert™ software suite which includes single-phase trapezoidal control and three-phase sensor-less Field Oriented Control (FOC) modules, speeding inverter development.

Key Points: 
  • BridgeSwitch-2 is supported by Power Integrations’ MotorXpert™ software suite which includes single-phase trapezoidal control and three-phase sensor-less Field Oriented Control (FOC) modules, speeding inverter development.
  • View the full release here: https://www.businesswire.com/news/home/20240610094341/en/
    Power Integrations revs up motor-drive offering with BridgeSwitch-2 BLDC IC family.
  • BLDC motor hardware-software combo slashes inverter sleep-mode consumption to less than 10 mW, expands output power to 1 HP.
  • For further information, contact a Power Integrations sales representative or one of the company’s authorized worldwide distributors— DigiKey , Newark , Mouser and RS Components , or visit power.com .

Spain Compact Construction Equipment Market Assessment 2023-2029 Featuring Prominent Vendors - Caterpillar, Komatsu, Volvo, Hitachi, JCB, SANY, Xuzhou, Kubota, Hyundai, Takeuchi and CNH - ResearchAndMarkets.com

Retrieved on: 
월요일, 6월 10, 2024
Other Construction & Property, Machinery, Construction & Property, Manufacturing, Hydrogen, MRR, Gold, CaixaForum Madrid, Bank, Compact, National bank, USD, Wind, ACS Group, Recovery, Climate, Ageing, LEED, Stagnation, Housing, AAC, Iberdrola, Cat, Climate change, Investment, Government, Electrolysis, BP, Caterpillar, Renewable energy

The "Spain Compact Construction Equipment Market - Strategic Assessment & Forecast 2023-2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Spain Compact Construction Equipment Market - Strategic Assessment & Forecast 2023-2029" report has been added to ResearchAndMarkets.com's offering.
  • Application of compact construction equipment in the material handling segment accounted for the largest share in 2022.
  • Rising investment in housing, warehouse expansion, and public infrastructure projects is expected to drive the demand for compact excavators in the Spain compact construction equipment market.
  • The digitization of construction equipment through advanced sensors, communication technology, and data analytics has revolutionized construction equipment.

Tradeweb and FTSE Russell Extend Benchmark Closing Prices to U.S. Treasury Markets

Retrieved on: 
월요일, 6월 10, 2024
Professional Services, Data Analytics, Finance, Fintech, Asset Management, Banking, Index, Treasury, Ecosystem, Data, TIPS, Cryptocurrency

Tradeweb and FTSE Russell today announced that they have launched Tradeweb FTSE U.S. Treasury Closing Prices, extending their combined offering of next generation fixed income pricing, which can be used in index trading products.

Key Points: 
  • Tradeweb and FTSE Russell today announced that they have launched Tradeweb FTSE U.S. Treasury Closing Prices, extending their combined offering of next generation fixed income pricing, which can be used in index trading products.
  • Similar to the existing Tradeweb FTSE closing prices for UK Gilts and European Government Bonds, these U.S. Treasury closing prices incorporate trading activity from Tradeweb’s electronic platform, which results in more robust benchmark pricing.
  • Tradeweb FTSE U.S. Treasury Closing Prices utilize an enhanced methodology, which facilitates the calculation of bid and offer prices, capturing transaction costs based on executable pricing quotes collected through the Tradeweb platform.
  • Tradeweb and FTSE Russell are committed to the continued expansion of their benchmark pricing coverage, and the incorporation of these prices throughout the investment process.

4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients

Retrieved on: 
월요일, 6월 10, 2024
Biotechnology, Physical Therapy, FDA, Health, General Health, Pharmaceutical, Research, Hospitals, Fitness & Nutrition, Science, Clinical Trials, Multimedia, Patient, Disease, Safety, Trial of the century, Pharmacokinetics, Liraglutide, OA, Success, Cmax, Pharmaceutical industry

4Moving Biotech, a spin-off of 4P-Pharma committed to developing first-in-class treatments to modify the natural course of knee osteoarthritis, announces the successful achievement of the Phase 1 Lasare trial in knee osteoarthritis (OA) patients using 4P004.

Key Points: 
  • 4Moving Biotech, a spin-off of 4P-Pharma committed to developing first-in-class treatments to modify the natural course of knee osteoarthritis, announces the successful achievement of the Phase 1 Lasare trial in knee osteoarthritis (OA) patients using 4P004.
  • View the full release here: https://www.businesswire.com/news/home/20240609275171/en/
    Lasare Phase I trial is a multi-center, randomized, double-blinded, placebo-controlled involving 34 patients across three sites in Belgium.
  • The study evaluated the safety, tolerability, and pharmacokinetics of ascending doses of a single intra-articular injection of liraglutide (4P004).
  • The trial reached its primary objective, confirming that intraarticular liraglutide (4P004) was safe and well tolerated.

Nest Seekers Expands Further into Greek Market and Launches European Headquarters of Nest Jets

Retrieved on: 
금요일, 6월 7, 2024
Construction & Property, Air, Transport, Urban Planning, Architecture, Transportation, Destinations, Travel, Residential Building & Real Estate, Jet stream, Elliniko, Nest Seekers International, EB-5 visa, Aviation, Lawyer, Foreign, Business, Seekers, Sky Express, Statistics, Business development

Nest Seekers International announces its further expansion into the Greek real estate market, with a significant focus on the Greek islands.

Key Points: 
  • Nest Seekers International announces its further expansion into the Greek real estate market, with a significant focus on the Greek islands.
  • This strategic move underscores Nest Seekers' commitment to providing unparalleled luxury property experiences in one of the world's most coveted destinations.
  • Nest Seekers Greek Islands is renowned for its expertise in facilitating EU residence, particularly through the Golden Visa program, ensuring a streamlined process for clients.
  • Statistics of buyers in the Greek real estate market reveal diverse preferences:
    Age Profile of Foreign Buyers: 41-50 years (37%), 51-60 years (36%), Over 61 years (16%), Under 40 years (11%)
    In addition to expanding its real estate presence, Nest Seekers Greek Islands announces the opening of the European Headquarters of Nest Jets.

BridgeBio Oncology Therapeutics announces first patient dosed with BBO-8520 in the Ph. 1 ONKORAS-101 trial for KRASG12C NSCLC

Retrieved on: 
목요일, 6월 6, 2024
Research, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Science, Oncology, Prognosis, Malignancy, Switch, GTP, Patient, National Cancer Institute, Doctor of Philosophy, Therapy, Switch II, Non-small-cell lung cancer, Theras, FDA, Pharmaceutical industry

BBO-8520 is a first-in-class orally bioavailable and highly potent small molecule direct inhibitor of KRASG12C (ON) state.

Key Points: 
  • BBO-8520 is a first-in-class orally bioavailable and highly potent small molecule direct inhibitor of KRASG12C (ON) state.
  • BBO-8520 binds covalently to the Switch II pocket in both the GTP-bound (ON) and GDP-bound (OFF) state conformations of KRASG12C, leading to rapid and sustained inhibition of KRASG12C activity.
  • On dosing the first patient, Professor Benjamin Solomon, head of lung medical oncology at the Peter MacCallum Cancer Center, said, “We are excited to partner with BridgeBio Oncology Therapeutics to bring a transformative new therapy to patients.
  • The ONKORAS-101 study will enroll patients pre-treated with first generation KRASG12C (OFF) inhibitors as well as patients with no prior KRASG12C targeted therapy experience.

The World Upholstered Furniture Industry 2024 - Spotlight on Top 20 Markets in the Global Upholstered Furniture Sector - ResearchAndMarkets.com

Retrieved on: 
목요일, 6월 6, 2024
Retail, Home Goods, Construction & Property, Interior Design, European, Growth, Furniture

The latest industry analysis presents an overview of the global upholstered furniture market, encompassing key aspects such as market size, production, and international trade from 2013-2022, with consumption forecasts extending to 2024.

Key Points: 
  • The latest industry analysis presents an overview of the global upholstered furniture market, encompassing key aspects such as market size, production, and international trade from 2013-2022, with consumption forecasts extending to 2024.
  • Analysis of the upholstered furniture industry highlights prominent markets, indicating trends in market growth, openness to imports, and leading exporting nations.
  • Projections of the world trade in upholstered furniture sketch a scenario up to 2024, incorporating industry dynamics and macroeconomic factors.
  • This industry analysis provides an indispensable resource for understanding the global upholstered furniture market, supporting businesses, investors, and policymakers in their strategic decision-making processes.

Theta Lake Delivers Voice Compliance Innovations Across Call Center, Enterprise Voice, Trader Voice, and Mobile Use Cases

Retrieved on: 
수요일, 6월 5, 2024
Technology, Security, Telecommunications, Professional Services, Business, Software, Audio, Video, Internet, Data Management, Artificial Intelligence, Theta, Cloud, RingCentral, WER, Communication, Symphony, Amazon Web Services, Organization, Geography, Cisco Webex, Meeting, GoTo Meeting, SMS, GDPR, Risk, Human, Patent, Word error rate, UC, PCI, Element, DCG, Microsoft, Mobile phone

As companies embrace alternatives to legacy voice and calling infrastructure and move to cloud-based unified communication-based phone and voice platforms, modern voice recording compliance approaches have become essential.

Key Points: 
  • As companies embrace alternatives to legacy voice and calling infrastructure and move to cloud-based unified communication-based phone and voice platforms, modern voice recording compliance approaches have become essential.
  • This shift to cloud-native voice presents new challenges for legacy compliance recording systems that are device and network-based, and Theta Lake is at the forefront of delivering innovative solutions to meet the need.
  • The message from regulators is clear: organizations must prioritize proper oversight and data retention across all communication channels, including voice and messaging.
  • “We’ve focused our integrations and efforts at Theta Lake on providing the broadest coverage for Cloud Voice Unified Communication platforms with the deepest DCG capabilities for compliance,” said Dan Nadir, Chief Product Officer, Theta Lake.